skin cancer Archives -

Sanofi/Regeneron’s Libtayo set for new skin cancer use

https://pharmaphorum.com/news/sanofi-regenerons-libtayo-set-for-new-skin-cancer-use/

Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1

https://pharmaphorum.com/news/almirall-strikes-option-deal-to-buy-bioniz-and-dermatology-drug-bnz-1/

Smartphone app provides skin cancer early warning service

https://pharmaphorum.com/news/smartphone-app-provides-skin-cancer-early-warning-service/

Immediately after EU nod, England’s NHS funds Sanofi skin cancer drug

https://pharmaphorum.com/news/immediately-after-eu-nod-englands-nhs-funds-sanofi-skin-cancer-drug/

InflaRx flatlines after skin disease drug flops in midstage trial

https://pharmaphorum.com/news/inflarx-flatlines-skin-disease-drug-midstage-trial/

https://pharmaphorum.com/news/nhs-funds-bms-opdivo-to-prevent-skin-cancer-returning/

Quality of life increasingly important in skin cancer, say doctors at this year’s ESMO

https://pharmaphorum.com/views-analysis-oncology/quality-of-life-increasingly-important-in-skin-cancer-esmo/

EU regulators back BMS’ Opdivo in new skin cancer use

https://pharmaphorum.com/news/eu-regulators-back-bms-opdivo-in-new-skin-cancer-use/

Incyte shares down sharply after phase 3 skin cancer trial failure

https://pharmaphorum.com/news/incyte-shares-down-sharply-after-phase-3-skin-cancer-trial-failure/

Search